ANTIDIABETOGENIC ACTION OF TRUNCATED GLUCAGON-LIKE PEPTIDE-1 IN MICE

被引:5
作者
AHREN, B
机构
[1] Department of Medicine, Lund University, Malmö
来源
ENDOCRINE | 1995年 / 3卷 / 05期
关键词
GLUCAGON-LIKE PEPTIDES-1(7-36)AMIDE; GLP-1; INSULIN SECRETION; GLUCOSE TOLERANCE; GLUCOSE ELIMINATION; DIABETES;
D O I
10.1007/BF03021420
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Besides its well-known stimulatory action on insulin secretion, glucagon-like peptide-1 (7-36)amide (= CLP-1) has been shown to increase the insulin-independent glucose uptake in normal individuals and the glucose elimination rate during short term conditions in diabetes. Whether such an action is evidented also in rodents and whether it persists after long-term administration are not known. This study therefore examined the influence of the peptide on glucose elimination in insulin deficient diabetic mice both acutely and following long-term administration. GLP-1 was injected intravenously (1 or 32 nmol/kg) together with glucose (2.8 mmol/kg) in both normal and alloxan-diabetic mice. It was found that the peptide at 32 nmol/kg potentiated the glucose elimination rate in both groups, i.e. also under insulin deficient conditions. In normal animals, GLP-1 also potentiated glucose-stimulated insulin secretion. In a second experimental series, GLP-1 was injected subcutaneously at 0.33:or 1.5 nmol twice daily to normal and alloxan-diabetic mice. After 5 days of treatment by the peptide at 1.5 nmol twice daily, the glucose elimination rate was potentiated in both groups, also when the intravenous glucose tolerance test was performed 4 h after the last injection of GLP-1. We therefore conclude that the glucose elimination is enhanced by GLP-1 in both normal and alloxan-diabetic mice, and that this effect persists after a 5 day course of subcutaneous treatment.
引用
收藏
页码:367 / 369
页数:3
相关论文
共 18 条
[1]   GLUCAGON-LIKE PEPTIDE-1 ENHANCES GLUCOSE-TOLERANCE BOTH BY STIMULATION OF INSULIN RELEASE AND BY INCREASING INSULIN-INDEPENDENT GLUCOSE DISPOSAL [J].
DALESSIO, DA ;
KAHN, SE ;
LEUSNER, CR ;
ENSINCK, JW .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (05) :2263-2266
[2]   GLP-1 AND GLP-17-36 AMIDE - INFLUENCES ON BASAL AND STIMULATED INSULIN AND GLUCAGON-SECRETION IN THE MOUSE [J].
FRIDOLF, T ;
BOTTCHER, G ;
SUNDLER, F ;
AHREN, B .
PANCREAS, 1991, 6 (02) :208-215
[3]   GLP-1(7-36)AMIDE-STIMULATED INSULIN-SECRETION IN RAT ISLETS IS SODIUM-DEPENDENT [J].
FRIDOLF, T ;
AHREN, B .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 179 (01) :701-706
[4]   GLUCOSE-DEPENDENCY OF THE INSULIN STIMULATORY EFFECT OF GLUCAGON-LIKE PEPTIDE-1 (7-36) AMIDE ON THE RAT PANCREAS [J].
GOKE, R ;
WAGNER, B ;
FEHMANN, HC ;
GOKE, B .
RESEARCH IN EXPERIMENTAL MEDICINE, 1993, 193 (02) :97-103
[5]   GLUCAGONLIKE PEPTIDE-1(7-36) AMIDE IS A NEW INCRETIN/ENTEROGASTRONE CANDIDATE [J].
GOKE, R ;
FEHMANN, HC ;
GOKE, B .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1991, 21 (02) :135-144
[6]   ANTIDIABETOGENIC EFFECT OF GLUCAGON-LIKE PEPTIDE-1 (7-36)AMIDE IN NORMAL SUBJECTS AND PATIENTS WITH DIABETES-MELLITUS [J].
GUTNIAK, M ;
ORSKOV, C ;
HOLST, JJ ;
AHREN, B ;
EFENDIC, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (20) :1316-1322
[7]   GLUCAGON-LIKE PEPTIDE-I-(7-37) SUPPRESSES HYPERGLYCEMIA IN RATS [J].
HENDRICK, GK ;
GJINOVCI, A ;
BAXTER, LA ;
MOJSOV, S ;
WOLLHEIM, CB ;
HABENER, JF ;
WEIR, GC .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1993, 42 (01) :1-6
[8]   TRUNCATED GLUCAGONLIKE PEPTIDE-I, AN INSULIN-RELEASING HORMONE FROM THE DISTAL GUT [J].
HOLST, JJ ;
ORSKOV, C ;
NIELSEN, OV ;
SCHWARTZ, TW .
FEBS LETTERS, 1987, 211 (02) :169-174
[9]  
HVIDBERG A, 1993, METABOLISM, V43, P104
[10]   ALLOXAN-INDUCED DIABETES IN THE MOUSE - TIME COURSE OF PANCREATIC B-CELL DESTRUCTION AS REFLECTED IN AN INCREASED ISLET VASCULAR-PERMEABILITY [J].
JANSSON, L ;
SANDLER, S .
VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1986, 410 (01) :17-21